Information recalled by women taking anti-epileptic drugs for epilepsy: A questionnaire study

Epilepsy Research

Volumn 52, Issue 2, 2002, Pages 139-146

  Bell, G S ^a,b   Nashef, L ^c,d   Kendall, S ^e   Solomon, J ^a   Poole, K ^a   Johnson, A L ^f   Moran, N F ^a   McCarthy, M ^g   McCormick, D ^d,h   Shorvon, S D ^a   Sander, J W ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^e UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^f MRC BIOSTATISTICS UNIT   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h GUY S HOSPITAL   (United Kingdom)

Author keywords

Anti epileptic drugs; Information recall; Questionnaire; Women with epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; FOLIC ACID; VITAMIN K GROUP;

ADOLESCENCE; ADOLESCENT; ADULT; AGE; ARTICLE; BREAST FEEDING; CHILD CARE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; RECALL; TERATOGENICITY; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTICONVULSANTS; ENGLAND; EPILEPSY; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MENTAL RECALL; MIDDLE AGED; PATIENT EDUCATION; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; QUESTIONNAIRES;

EID: 0036891373     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(02)00135-3     Document Type: Article

References (19)

1. Bell G.S., Sander J.W. The epidemiology of epilepsy: the size of the problem. Seizure. 10:(4):2001;306-314.
2. British National Formulary, 2001. British National Formulary, Vol. 42.
3. CSAG. Services for Patients with Epilepsy. 2000;Department of Health.
4. Craig J., Morrison P., Morrow J., Patterson V. Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate. Seizure. 8:(4):1999;253-254.
5. Crawford P., Lee P. Gender difference in management of epilepsy - what women are hearing. Seizure. 8:(3):1999;135-139.
6. Crawford P., Appleton R., Betts T., Duncan J., Guthrie E., Morrow J. Best practice guidelines for the management of women with epilepsy. The women with Epilepsy Guidelines Development Group. Seizure. 8:(4):1999;201-217.
7. Deblay M.F., Vert P., Andre M., Marchal F. Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother. Lancet. 1:1982;1247.
8. Fairgrieve S.D., Jackson M., Jonas P., Walshaw D., White K., Montgomery T.L., Burn J., Lynch S.A. Population based, prospective study of the care of women with epilepsy in pregnancy. Br. Med. J. 321:2000;674-675.
9. Fox C., Betts T. How much risk does a woman with active epilepsy pose to her newborn child in the puerperium? A pilot study. Seizure. 8:(6):1999;367-369.
10. Hernandez-Diaz S., Werler M.M., Walker A.M., Mitchell A.A. Folic acid antagonists during pregnancy and the risk of birth defects. New Engl. J. Med. 343:(22):2000;1608-1614.
11. Krauss G.L., Brandt J., Campbell M., Plate C., Summerfield M. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians. Neurology. 46:(6):1996;1534-1539.
12. Kravitz R.L., Hays R.D., Sherbourne C.D., DiMatteo M.R., Rogers W.H., Ordway L., Greenfield S. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch. Intern. Med. 153:(16):1993;1869-1878.
13. Moran N., Poole K., Bell G., Solomon J., Kendall S., McCarthy M., McCormick D., Nashef L., Johnson A., Sander J., Shorvon S. NHS Services for Epilepsy from the patient's perspective: a survey of primary, secondary and tertiary care access throughout the UK. Seizure. 9:2000;559-565.
14. Morrell M.J. Guidelines for the care of women with epilepsy. Neurology. 51:(5 Suppl. 4):1998;S21-S27.
15. Mountain K.R., Hirsh J., Gallus A.S. Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet. 1:1970;265-268.
16. Nakane Y., Okuma T., Takahashi R., Sato Y., Wada T., Sato T., Fukushima Y., Kumashiro H., Ono T., Takahashi T., Aoki Y., Kazamatsuri H., Inami M., Komai S., Seino M., Miyakoshi M., Tanimura T., Hazama H., Kawahara R., Otsuki S., Hosokawa K., Inanaga K., Nakazawa Y., Yamamoto K. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia. 21:(6):1980;663-680.
17. Poole K., Moran N., Bell G., Solomon J., Kendall S., McCarthy M., Nashef L., Johnson A., Sander J., Shorvon S. Patients' perspectives on services for epilepsy: a survey of patient satisfaction, preferences and information provision in 2394 people with epilepsy. Seizure. 9:2000;551-558.
18. Scally G. Tackling teenage pregnancy in the UK. Lancet. 353:1999;2178.
19. Scottish Obstetric Guidelines and Audit Project, 1997. The Management of Pregnancy in Women with Epilepsy.